Results 11 to 20 of about 2,520 (194)
Cloning and characterization of the human USP22 gene promoter. [PDF]
Ubiquitin-specific processing enzyme 22 (USP22) plays a direct role in regulating cell cycle, and its overexpression has been reported to be involved in tumor progression. However, little is known about the regulation of USP22 transcription.
Jianjun Xiong +5 more
doaj +5 more sources
A positive feedback loop of SRSF9/USP22/ZEB1 promotes the progression of ovarian cancer [PDF]
Ovarian cancer (OC) is recognized as the most lethal type of gynecological malignancy, making treatment options challenging. Discovering novel therapeutic targets will benefit OC patients. This study aimed to reveal the mechanism by which SRSF9 regulates
Jing Wang, Ming Hu, Jie Min, Xin Li
doaj +3 more sources
USP22 promotes gefitinib resistance and inhibits ferroptosis in non‐small cell lung cancer by deubiquitination of MDM2 [PDF]
Background The emergence of chemoresistance markedly compromised the treatment efficiency of human cancer, including non‐small cell lung cancer (NSCLC). In the present study, we aimed to explore the effects of ubiquitin‐specific peptidase 22 (USP22) and ...
Peng Lu, Zhaoguo Li, Hang Xu
doaj +3 more sources
Deubiquitination in prostate cancer progression: role of USP22 [PDF]
Prostate cancer (PCa) is the leading cause of cancer death in men. With more therapeutic modalities available, the overall survival in PCa has increased significantly in recent years. Patients with relapses after advanced secondgeneration anti-androgen therapy however, often show poor disease prognosis.
Nag, Nivedita, Dutta, Samikshan
openaire +3 more sources
Background/Aims: The ubiquitin-specific peptidase USP22 mediates various cellular and organismal processes, such as cell growth, apoptosis, and tumor malignancy.
Ning Ao +7 more
doaj +2 more sources
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells [PDF]
Background Many cancers evade immune surveillance by overexpressing PD-L1. PD-L1 interacted with its receptor PD-1, resulting in reduction of T cell proliferation and activation and thereafter cancer cell death mediated by T-lymphocyte. Understanding the
Yu Wang +7 more
doaj +3 more sources
Usp22 deficiency impairs intestinal epithelial lineage specification in vivo [PDF]
Epigenetic regulatory mechanisms play a central role in controlling gene expression during development, cell differentiation and tumorigenesis. Monoubiquitination of histone H2B is one epigenetic modification which is dynamically regulated by the opposing activities of specific ubiquitin ligases and deubiquitinating enzymes (DUBs).
Kosinsky, Robyn L. +7 more
openaire +7 more sources
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a common solid tumor with high rate of recurrence and mortality. Anti-angiogenesis drugs have been used for the therapy of HCC. However, anti-angiogenic drug resistance commonly occurs during HCC treatment.
Kai Zeng +16 more
doaj +3 more sources
Varions Mechanisms of Deubiquitinating Enzyme USP22 in Cancer
Ubiquitin specific proteases 22 (USP22) is a highly conserved ubiquitin hydrolase in mammals. It mainly prevents proteins degradation by deubiquitinating substrate proteins and regulates life processes such as genetic transcription, DNA damage repair and
SUN Yue, HAN Bing, ZHEN Fang, HU Jing
doaj +2 more sources
USP22 is a positive regulator of NFATc2 on promoting IL2 expression [PDF]
Nuclear factor of activated T cells (NFAT) is an important regulator of T cell activation. However, the molecular mechanism whereby NFATc2 regulates IL2 transcription is not fully understood. In this study, we showed that ubiquitin‐specific protease 22 (USP22), known as a cancer stem cell marker, specifically interacted with and deubiquitinated NFATc2.
Gao, Yayi +15 more
openaire +3 more sources

